title: Moving Beyond Directly Observed Therapy for Tuberculosis.
authors.affiliation: Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America.
authors.forename: John Z
authors.initials: JZ
authors.lastname: Metcalfe
authors.affiliation: Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Center, New York, New York, United States of America.
authors.forename: Max R
authors.initials: MR
authors.lastname: O'Donnell
authors.affiliation: Massachusetts General Hospital, Harvard Medical School, Harvard School of Public Health, Boston, Massachusetts, United States of America; Mbarara University of Science and Technology, Mbarara, Uganda.
authors.forename: David R
authors.initials: DR
authors.lastname: Bangsberg
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D023801:Directly Observed Therapy; D024881:Drug Resistance, Bacterial; D006801:Humans; D055118:Medication Adherence; D014376:Tuberculosis / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents